8月20日，三生制药盘中上涨5.15%，报17.55港元，成交额545.19万港元。
消息面上，公司董事会于今日召开会议审议并批准刊发截至6月30日止六个月的未经审核中期业绩，并考虑派发中期股息。市场对中报业绩存在积极预期，此前有机构指出公司坐拥特比澳等多个现金牛品种，高毛利率水平下盈利弹性值得关注。此外，公司董事长6月曾斥资约787万港元增持股份，6月期间还累计回购约852万股，释放管理层信心信号。同日生物科技板块整体走强，云顶新耀涨49.24%，康方生物涨6.33%，信达生物涨5.24%，科伦博泰生物涨4.01%，百济神州涨3.85%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.